A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia.
Phase of Trial: Phase II/III
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 28 Feb 2018 Meta-analysis of this study has been reported in UMIN-CTR clinical trial(UMIN000031422' reciept number: R000035871) assessing drug response in Japanese patients with schizophrenia based on information in clinical evaluation index and genetic information collected from those patients who have attended this clinical trial.
- 05 Oct 2016 Status changed from active, no longer recruiting to completed.
- 15 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.